ADMA INVESTOR UPDATE: ADMA Biologics, Inc. Stock Drops 20% after Auditor Resigns; Contact BFA Law if You Suffered Losses on Your Investment
NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/adma-biologics-inc. Why Did ADMA Biologics’s […]